Alignment Healthcare (ALHC) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Jul, 2026Executive summary
Health plan membership grew 31.5% year-over-year to 294,100 as of June 30, 2026, driving a 31.6% increase in quarterly revenues to $1.34 billion and a 32.4% increase in six-month revenues to $2.57 billion.
Net income for Q2 2026 was $36.6 million, up from $15.7 million in Q2 2025, with adjusted EBITDA rising 48.4% to $68.1 million (5.1% margin).
The medical benefits ratio (MBR) improved to 86.3% from 86.7% year-over-year, reflecting effective cost management.
Investments in AI, clinical operations, and automation are supporting both near-term efficiency and long-term scalability.
Embedded gross profit potential within current membership has grown to $880 million, with 2026 full-year guidance midpoint at $640 million adjusted gross profit.
Financial highlights
Adjusted gross profit for Q2 2026 was $182.9 million, up 35.3% year-over-year, with an adjusted MBR of 86.3%.
Adjusted SG&A was $115 million (8.6% of revenue), improving 20 basis points year-over-year.
Operating cash flow for the first half was $111.4 million, up from $45.7 million in the prior year; liquidity at quarter-end was $701.7 million in cash and equivalents.
Funded leverage ratio improved to 2.2x trailing 12-month EBITDA.
Quarterly income from operations increased 85.1% to $42.1 million; net income margin rose to 2.7% of revenue.
Outlook and guidance
Full-year 2026 guidance: membership 298,000–301,000; revenue $5.20–$5.23 billion; adjusted gross profit $630–$650 million; Adjusted EBITDA $145–$163 million.
Q3 2026 guidance: membership 295,500–297,500; revenue $1.30–$1.32 billion; adjusted gross profit $148–$158 million; Adjusted EBITDA $20–$30 million.
Raised full-year revenue and profitability guidance following strong first half; expect 30% of full-year Adjusted EBITDA in the second half.
Management expects continued investment in technology, market expansion, and product innovation to drive future growth.
Cash flows and liquid assets are expected to be sufficient to fund operations and capital needs for at least the next 12 months.
Latest events from Alignment Healthcare
- Data-driven care and operational discipline fuel growth, with stable outlook and expanding markets.ALHC
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Stable trends, tech-driven growth, and expanding margins drive strong outlook and scalability.ALHC
Bank of America Global Healthcare Conference 2026 - Leadership structure updated with new Chair, Vice Chair, and executive appointments.ALHC
Proxy filing - Revenue up 33%, net income positive, and margin expansion drives strong Q1 results.ALHC
Q1 2026 - Board recommends approval of all proposals amid strong growth, governance, and ESG focus.ALHC
Proxy filing - Virtual meeting to vote on directors, auditor, and executive pay, with board support for all.ALHC
Proxy filing - Disciplined growth, robust retention, and scalable care models drive strong performance.ALHC
Leerink Global Healthcare Conference 2026 - Q2 revenue rose 47% and membership 56%, with improved margins and raised 2024 guidance.ALHC
Q2 2024 - Q1 2025 revenue rose 47.5% with higher guidance, margin gains, and a CFO transition.ALHC
Q1 2025